Literature DB >> 398209

Hemodialysis in schizophrenia. Results in three chronic cases.

M Fischler, H M Emrich, W Kissling, D von Zerssen, H Riedhammer, H H Edel.   

Abstract

Therapeutic trials with hemodialysis have been performed in three cases of chronic schizophrenia. The severely ill patients had been hospitalized for more than ten years and had not responded to different types of conventional somatic treatment. Psychopathology was evaluated by use of the IMPS, BPRS, and NOSIE scales. No improvement could be observed as a consequence of 12 (11 in one case) hemodialysis treatments. Rather, some deterioration occurred in two of the patients. This result is not in accord with the markedly positive findings of Wagemaker and Cade (1977). However, further studies appear necessary to render final conclusions.

Entities:  

Mesh:

Year:  1979        PMID: 398209     DOI: 10.1007/bf00367391

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  7 in total

1.  Hemodialysis in schizophrenia.

Authors:  H FEER; H THOELEN; M A MASSINI; H STAUB
Journal:  Compr Psychiatry       Date:  1960-12       Impact factor: 3.735

2.  Can dialysis help the chronic schizophrenic?

Authors: 
Journal:  Am J Psychiatry       Date:  1977-11       Impact factor: 18.112

3.  The use of hemodialysis in chronic schizophrenia.

Authors:  H Wagemaker; R Cade
Journal:  Am J Psychiatry       Date:  1977-06       Impact factor: 18.112

4.  Recommendations for the evaluation of possible therapeutic effects of blood purification methods in chronic schizophrenic patients.

Authors:  H Hippius; N Matussek; N Nedopil; A Strauss; G D von Zerssen; H Emrich; W J Kolff; H J Gurland
Journal:  Artif Organs       Date:  1979-02       Impact factor: 3.094

5.  The effect of hemodialysis on schizophrenia: a survey of patients with renal failure.

Authors:  F K Port; P D Kroll; R D Swartz
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

6.  beta-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders.

Authors:  H M Emrich; V Höllt; W Kissling; M Fischler; H Laspe; H Heinemann; D von Zerssen; A Herz
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1979-05

7.  [On the use of the artificial kidney in schizophrenia and myasthenia gravis].

Authors:  H THOELEN; E STRICKER; H FEER; M A MASSINI; H STAUB
Journal:  Dtsch Med Wochenschr       Date:  1960-06-03       Impact factor: 0.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.